KRAS and endometrioid tumor: Type I tumors are characterized by other mutations (including KRAS, BRAF, PTEN, and PIK3CA and others shown in Table 5) [12], and we observed that all 15 endometrioid tumors in the Wu dataset with CTNNB1, PTEN, or PIK3CA mutations were characterized as differentiated.